Gut Liver.
2022 Jan;16(1):138-140. 10.5009/gnl210246.
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
- Affiliations
-
- 1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2524771
- DOI: http://doi.org/10.5009/gnl210246
Abstract
- No abstract available
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Golimumab Therapy in Ulcerative Colitis
- Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
- Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
- Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis
- Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
